Survivorship after cancer can be harder than treatment. My daughter faces lasting side effects, fear, and uncertainty while ...

Treating patients with lung cancer always calls for a focus on informed and shared decision-making, according to expert ...

I was told I wouldn’t live to see my daughters’ weddings — but 12 years later, I’ve been there for two, and I’m holding out ...

Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

Dr. Aaron Gerds breaks down the outcomes of the phase 3 VERIFY trial, investigating rusfertide, for patients with polycythemia vera, a type of blood cancer.

Dr. Joshua K. Sabari and Dr. Prantesh Jain delve into key lung cancer outcomes from the 2025 ASCO Meeting that patients should be aware of.

Joining support groups after cancer treatment helped me heal emotionally, connect with others who understood and embrace a ...

The FDA has granted approval to UGN-102 for use in patients with low-grade intermediate-risk non-muscle-invasive bladder ...

Eminem’s lyric about having “one shot” stayed with me, and writing this letter to my newly diagnosed self, reminds me how ...

Dr. Joshua K. Sabari and Dr. Daniel V. Araujo provide expert insights into genitourinary cancer updates from ASCO 2025.

Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination ...

FDA approves new Brukinsa tablet for five blood cancers, offering simpler dosing with the same safety and effectiveness as ...